Neonatal estrogen exposure alters the transforming growth factor-β signaling system in the developing rat prostate and blocks the transient p21cip1/waf1 expression associated with epithelial differentiation

被引:34
作者
Chang, WY
Birch, L
Woodham, C
Gold, LI
Prins, GS
机构
[1] Univ Illinois, Coll Med, Dept Urol, Chicago, IL 60612 USA
[2] Univ Illinois, Coll Med, Dept Physiol & Biophys, Chicago, IL 60612 USA
[3] NYU, Sch Med, New York, NY 10016 USA
关键词
D O I
10.1210/en.140.6.2801
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Exposure of male rats to estrogens during the neonatal period retards prostate branching morphogenesis, blocks epithelial differentiation, and predisposes the adult prostate to hyperplasia and dysplasia. The mechanism of neonatal estrogenization is not well understood. The present study evaluated transforming growth factor-beta (TGF beta) in the neonatally estrogenized ventral prostate to determine whether this paracrine/autocrine factor may in part mediate the effects of estrogen on the developing prostate gland. Immunocytochemistry using antibodies against active TGF beta 1 and its latency-associated peptide localized this molecule to the periductal smooth muscle cells in the developing prostate. Although neonatal estrogenization increased the accumulation of total and active TGF beta 1 in the smooth muscle layer as early as day 6 of life, it was physically separated from the epithelial ducts by a proliferating layer of fibroblasts surrounding the basement membrane. RT-PCR demonstrated that alterations in TGF beta 1 levels were not due to alterations in TGF beta 1 transcription. TGF beta 2 and TGF beta 3 were primarily immunolocalized to differentiating epithelial cells in developing prostates, and this was markedly damp ened between days 10-30 after neonatal estrogen exposure. Immunocytochemistry for TGF beta signaling components revealed that neonatal estrogenization transiently reduced TGF beta type I receptor levels in the prostate epithelium, but not in stroma, between days 6-15, whereas there was no effect on TGF beta type II receptor. Levels of the intracellular signal Smad2 (52 kDa) were detected in epithelial cells but were not altered after estrogenization. To analyze the functional status of the TGF beta signaling pathway, immunocytochemistry was performed for p21(cip-1/waf-1), a cyclin-dependent kinase inhibitor that is inducible by TGF beta 1 in the prostate. Transient nuclear localization of p21(cip-1/waf-1) was normally observed in epithelial cells between days 6-15 and was associated with entry of cells into a terminal differentiation pathway. Neonatal estrogenization prevented this transient expression of p21(cip-1/waf-1). The present findings demonstrate that the TGF beta signaling system is perturbed at several levels in the estrogenized prostate, which may in part account for the epithelial cell differentiation blockade as well as the proliferation of periductaI fibroblasts in this model.
引用
收藏
页码:2801 / 2813
页数:13
相关论文
共 56 条
[1]  
[Anonymous], PROSTATE BASIC CLIN
[2]  
ARAI Y, 1978, GANN, V69, P861
[3]   Latency and Activation in the Control of TGF-β [J].
Barcellos-Hoff, Mary Helen .
JOURNAL OF MAMMARY GLAND BIOLOGY AND NEOPLASIA, 1996, 1 (04) :353-363
[4]   TRANSFORMING GROWTH-FACTOR-BETA ACTIVATION IN IRRADIATED MARINE MAMMARY-GLAND [J].
BARCELLOSHOFF, MH ;
DERYNCK, R ;
TSANG, MLS ;
WEATHERBEE, JA .
JOURNAL OF CLINICAL INVESTIGATION, 1994, 93 (02) :892-899
[5]  
BARCELLOSHOFF MH, 1995, AM J PATHOL, V147, P1228
[6]   THE CELL BIOLOGY OF TRANSFORMING GROWTH-FACTOR-BETA [J].
BARNARD, JA ;
LYONS, RM ;
MOSES, HL .
BIOCHIMICA ET BIOPHYSICA ACTA, 1990, 1032 (01) :79-87
[7]   TRANSFORMING GROWTH FACTOR-BETA(1)-LIKE IMMUNOREACTIVITY IN THE PITUITARY-GLAND OF THE RAT - EFFECT OF ESTROGEN [J].
BURNS, G ;
SARKAR, DK .
ENDOCRINOLOGY, 1993, 133 (03) :1444-1449
[8]  
CHAN YL, 1987, J BIOL CHEM, V262, P1111
[9]   Neonatal estrogen stimulates proliferation of periductal fibroblasts and alters the extracellular matrix composition in the rat prostate [J].
Chang, WY ;
Wilson, MJ ;
Birch, L ;
Prins, GS .
ENDOCRINOLOGY, 1999, 140 (01) :405-415
[10]  
CHUNG LWK, 1980, INVEST UROL, V17, P337